Welcome to LookChem.com Sign In|Join Free
  • or
2,6-dimethylpyridine-3,5-dicarbohydrazide, also known as DMPD, is an organic compound characterized by its molecular formula C9H14N4O2. It is a white to off-white crystalline powder with a slight odor, and it is recognized for its low toxicity. DMPD is valued for its role as a curing agent in the production of epoxy resins and adhesives, where it functions as a hardener to enhance the strength and durability of these materials.

5317-07-7

Post Buying Request

5317-07-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5317-07-7 Usage

Uses

Used in the Production of Epoxy Resins and Adhesives:
2,6-dimethylpyridine-3,5-dicarbohydrazide is used as a curing agent for improving the strength and durability of epoxy resins and adhesives. Its hardening properties make these materials suitable for a wide range of industrial applications, ensuring their reliability and performance under various conditions.
Used in the Synthesis of Pharmaceuticals:
DMPD is utilized as a key intermediate in the synthesis of pharmaceuticals, contributing to the development of new drugs with potential therapeutic benefits. Its chemical properties allow for versatile reactions and modifications, facilitating the creation of diverse medicinal compounds.
Used in the Synthesis of Pesticides:
In the agricultural sector, 2,6-dimethylpyridine-3,5-dicarbohydrazide is employed in the synthesis of pesticides. Its role in creating effective and targeted pest control agents helps protect crops and enhance agricultural productivity while ensuring the safety and sustainability of food production.
It is important to handle 2,6-dimethylpyridine-3,5-dicarbohydrazide with care and follow appropriate safety measures during its use, given its classification as a chemical substance.

Check Digit Verification of cas no

The CAS Registry Mumber 5317-07-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,3,1 and 7 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 5317-07:
(6*5)+(5*3)+(4*1)+(3*7)+(2*0)+(1*7)=77
77 % 10 = 7
So 5317-07-7 is a valid CAS Registry Number.

5317-07-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-Benzylimidazole-5-carboxylic Acid

1.2 Other means of identification

Product number -
Other names 1-Benzylimidazole-5-carboxylic Acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5317-07-7 SDS

5317-07-7Relevant academic research and scientific papers

N-cyclopropyl methoxy imidazole amide derivative and application thereof in antitumor drugs

-

, (2021/10/27)

The invention belongs to the technical field of medicinal chemistry, and particularly relates to N-cyclopropyl methoxy imidazole amide derivatives, a preparation method and application of the N-cyclopropyl methoxy imidazole amide derivatives as an MEK inhibitor in antitumor drugs. The invention provides an N-cyclopropyl methoxy imidazole amide derivative as shown in a general formula, and geometric isomers or pharmaceutically acceptable salts, hydrates, solvates or prodrugs of the N-cyclopropyl methoxy imidazole amide derivative. The MEK inhibitor provided by the invention has specificity and effectiveness, and has a wider development prospect. Experimental results show that the N-cyclopropyl methoxy imidazole amide derivative synthesized by the research group has a prospect of developing targeted antitumor drugs.

Design, synthesis and evaluation of 1-benzyl-1H-imidazole-5-carboxamide derivatives as potent TGR5 agonists

Zhao, Shizhen,Li, Xinping,Wang, Le,Peng, Wenjing,Ye, Wenling,Li, Weiguo,Wang, Yan-Dong,Chen, Wei-Dong

, (2021/01/18)

TGR5 is emerging as an important and promising target for the treatment of diabetes, obesity and other metabolic syndromes. A series of novel 1-benzyl-1H-imidazole-5-carboxamide derivatives was designed, synthesized and evaluated in vitro and in vivo. The

Synthesis of 1-benzyl-8,9-dihydroimidazo[4,5-c]pyrrolo[3,2-g]quinolin-4(5H) -one via palladium-catalyzed intramolecular arylation

Delest, Bruno,Tisserand, Jean-Yves,Robert, Jean-Michel,Nourrisson, Marie-Renée,Pinson, Patricia,Duflos, Muriel,Le Baut, Guillaume,Renard, Pierre,Pfeiffer, Bruno

, p. 6079 - 6083 (2007/10/03)

The synthesis of a novel tetracyclic structure, 8,9-dihydroimidazo[4,5-c] pyrrolo[3,2-g]quinolin-4(5H)-one, has been achieved by a convergent pathway. Coupling of the weakly nucleophilic hindered aromatic amine with 1-benzylimidazole-4-carboxylic acid, 7, afforded the corresponding amide 9 using a DCP/DMF complex; subsequent Heck-type arylation leading to desired tetracyclic molecule imidazo[4,5-c]-pyrrolo[3,2-g]quinolin-4(5H)-one.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5317-07-7